GLP-3 Reta

Retatrutide (LY3437943) is an investigational research peptide with agonist activity at the GIP, GLP-1, and glucagon receptors. Celtek Retatrutide is independently analyzed by HPLC and mass spectrometry with lot-specific testing documentation. Supplied in lyophilized form for laboratory research use only. 2nd Day Air shipping is included.

Quality Guarantee

Reconstitution: Recommended for laboratory titration using bacteriostatic water.

Shipping Included

Every standard Celtek order includes 2nd Day Air shipping in the product price.

For projects that require faster delivery, Next Day Air is available for an additional charge.

Research Use Only

FOR RESEARCH USE ONLY. NOT FOR HUMAN OR VETERINARY USE.

This product is intended solely for legitimate laboratory research and development.

It is not intended for human administration, veterinary administration, diagnostic use, therapeutic use, food use, cosmetic use, or dietary supplementation.

Retatrutide remains investigational. The presence of published clinical research involving retatrutide does not mean that Celtek research material is equivalent to material used in pharmaceutical clinical trials or approved for medical use.

Description

Retatrutide Research Peptide

Retatrutide, also known as LY3437943, is an investigational synthetic peptide developed as a unimolecular agonist of the GIP, GLP-1, and glucagon receptors. It has become an important research compound in studies of metabolic signaling, receptor pharmacology, glucose regulation, energy balance, and peptide drug design.

Celtek Retatrutide is supplied strictly for laboratory research and development use. Each lot is independently analyzed using HPLC and mass spectrometry, with lot-specific analytical documentation available through our Testing & COA library.

Product Details

  • Compound: Retatrutide
  • Development Code: LY3437943
  • Research Class: GIPR / GLP-1R / GCGR triple agonist
  • Form: Lyophilized peptide
  • Purity: 99%+ where confirmed by the applicable lot-specific HPLC analysis
  • Identity Testing: Mass spectrometry
  • Testing: Independent third-party analysis
  • Documentation: Lot-specific Certificate of Analysis
  • Shipping: 2nd Day Air included
  • Next Day Air: Available for an additional charge

About Retatrutide

Retatrutide is a single engineered peptide designed to activate three related G-protein-coupled receptors:

GIP receptor (GIPR)
GLP-1 receptor (GLP-1R)
Glucagon receptor (GCGR)

This triple-receptor profile distinguishes retatrutide from single GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists.

Published preclinical and clinical research has examined retatrutide in areas including receptor signaling, metabolic regulation, body composition, glucose metabolism, liver fat, lipid metabolism, and obesity-related disease.

Retatrutide remains an investigational compound and is not an FDA-approved drug.

Independent Analytical Testing

Each Celtek Retatrutide lot is independently analyzed to provide researchers with information about the material being supplied.

Testing includes:

HPLC analysis to characterize chromatographic purity.

Mass spectrometry to provide evidence supporting molecular identity.

The applicable lot number connects the physical research material to its analytical documentation.

Researchers can review current testing through our Testing & Certificates of Analysis section.

Lot-Specific Documentation

We do not rely on a generic purity statement that is reused indefinitely.

Each current lot is associated with its own analytical documentation so researchers can verify the testing connected to the material they receive.

The process is straightforward:

Retatrutide → Lot Number → Analytical Report

This provides clearer traceability between the research material and its supporting data.

Additional information

Size

10mg, 20mg, 30mg, 40mg, 50mg, 60mg

Related Products